Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
Open Access
- 15 October 2021
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Videosurgery and Other Miniinvasive Techniques
- Vol. 19 (5), 1410-1420
- https://doi.org/10.5114/aoms/142103
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection...This publication has 59 references indexed in Scilit:
- Vaccine delivery using nanoparticlesFrontiers in Cellular and Infection Microbiology, 2013
- Preparation and Efficacy of a Live Newcastle Disease Virus Vaccine Encapsulated in Chitosan NanoparticlesPLOS ONE, 2012
- Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand T fh cells and promote germinal center inductionProceedings of the National Academy of Sciences of the United States of America, 2012
- T cell exhaustionNature Immunology, 2011
- Biological Gene Delivery Vehicles: Beyond Viral VectorsMolecular Therapy, 2009
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticlesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer VectorsHuman Gene Therapy, 2006
- Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA deliveryAdvanced Drug Delivery Reviews, 2005
- Immune responses to gene therapy vectors: influence on vector function and effector mechanismsGene Therapy, 2004